|
Are you attending the ASGCT 27th Annual Meeting? If you’re interested in accelerating gene therapy discovery or streamlining the road to cell therapy manufacturing, it's the perfect moment to connect with our team of experts. Let’s talk about how you can take advantage of our integrated iPSC-based platform. |
An iPSC Based Platform to Develop AAV Gene Therapies for ALS Using Specific and Robust Phenotypic Assays Covering Multiple Disease-Relevant Readouts
Abstract #632
Session: May 8 at 12 PM, Neurologic Diseases
Evaluating the Transduction Efficiency of Different AAV Serotypes on hiPSC Derived Cardiomyocytes
Abstract #607
Session: May 8 at 12 PM, Heart, Lung and Kidney Diseases
Learn more about the conference here.